Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 88 days for 2021).
- 2025not filed
- 202408/07/2025
- 202316/07/2024
- 202203/07/2023
- 202111/10/2022
- 202028/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2012.
| Mark | Protected until | |
|---|---|---|
| BOWIL (word) | Jul 11, 2032 | |
| BOWIL BIOTECH (word) | – | |
| celmat (word) | – |
Authorized Representatives
Manner of representation
To make declarations of will and sign on behalf of the company, each member of the management board is authorized to act independently, regardless of the function held.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 4,800 | $648,298.22 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2007-09-27 to 2026-01-14.
Reason for removal: Art. 96 ust. 6-8
Debt
No entries in the National Debtors Register (KRZ).
Public aid
13 public aid cases recorded, with a total value of $350,238.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 5, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,964$3,964 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 31, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,961$2,961 | Prezes Banku Gospodarstwa Krajowego | |
| Jul 21, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,936$1,936 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2016-06-01 | Increasing the competitiveness and reach of Bowil Biotech by entering new international sales markets through an investment to launch production of a new biomaterial for manufacturing implants, resulting from the company's own research and development work | $247.7K$247,735 | Regional Operational Programme for the Pomorskie Voivodeship for 2014–2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biovico sp. z o.o. | $32,559,077.90 | biovico.com | ||
| Fabryka Aparatury Elektromedycznej Famed Łódź S.A. | $1,968,148.73 | famed.pl | ||
| Bifarm sp. z o.o. | $1,858,549.39 | bifarm.pl | ||
| Esvico sp. z o.o. | $1,710,090.76 | esvimed.pl | ||
| Metzer Medizin- Und Industrietechnik sp. z o.o. | $1,511,723.18 | metzer.pl | ||
| Profildent sp. z o.o. | $1,479,140.15 | profildent.pl | ||
| Jacek Bartosik sp. k. | $1,195,667.44 | sferaoczu.pl | ||
| Optyk Plus sp. z o.o. | $971,746.64 | optyk-plus.pl | ||
| Implai sp. z o.o. | $661,746.96 | implai.com | ||
| Pressdots Technology sp. z o.o. | $270,666.62 | pressdots.pl |
FAQ
Last updated: 2026-02-17